Detalles de la búsqueda
1.
Considerations for using potential surrogate endpoints in cancer screening trials.
Lancet Oncol
; 25(5): e183-e192, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38697164
2.
A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19.
N Engl J Med
; 384(10): 905-914, 2021 03 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33356051
3.
Towards a multi-arm multi-stage platform trial of disease modifying approaches in Parkinson's disease.
Brain
; 146(7): 2717-2722, 2023 07 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36856727
4.
When should factorial designs be used for late-phase randomised controlled trials?
Clin Trials
; 21(2): 162-170, 2024 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37904490
5.
REFINE-Lung implements a novel multi-arm randomised trial design to address possible immunotherapy overtreatment.
Lancet Oncol
; 24(5): e219-e227, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37142383
6.
Tumour stage, treatment, and survival of women with high-grade serous tubo-ovarian cancer in UKCTOCS: an exploratory analysis of a randomised controlled trial.
Lancet Oncol
; 24(9): 1018-1028, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37657461
7.
Which patients with metastatic hormone-sensitive prostate cancer benefit from docetaxel: a systematic review and meta-analysis of individual participant data from randomised trials.
Lancet Oncol
; 24(7): 783-797, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37414011
8.
Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol.
Lancet
; 399(10323): 447-460, 2022 01 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-34953525
9.
Ovarian cancer symptoms in pre-clinical invasive epithelial ovarian cancer - An exploratory analysis nested within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).
Gynecol Oncol
; 179: 123-130, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37980767
10.
Treatment selection in multi-arm multi-stage designs: With application to a postpartum haemorrhage trial.
Clin Trials
; 20(1): 71-80, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36647713
11.
A comparison of different population-level summary measures for randomised trials with time-to-event outcomes, with a focus on non-inferiority trials.
Clin Trials
; 20(6): 594-602, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37337728
12.
Evaluating Primary Endpoints for COVID-19 Therapeutic Trials to Assess Recovery.
Am J Respir Crit Care Med
; 206(6): 730-739, 2022 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35580040
13.
Responses to a Neutralizing Monoclonal Antibody for Hospitalized Patients With COVID-19 According to Baseline Antibody and Antigen Levels : A Randomized Controlled Trial.
Ann Intern Med
; 175(2): 234-243, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34928698
14.
artcat: Sample-size calculation for an ordered categorical outcome.
Stata J
; 23(1): 3-23, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-37155554
15.
artbin: Extended sample size for randomized trials with binary outcomes.
Stata J
; 23(1): 24-52, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-37461744
16.
Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal cancer treatment (ICON8): overall survival results from an open-label, randomised, controlled, phase 3 trial.
Lancet Oncol
; 23(7): 919-930, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35690073
17.
Radiotherapy to the prostate for men with metastatic prostate cancer in the UK and Switzerland: Long-term results from the STAMPEDE randomised controlled trial.
PLoS Med
; 19(6): e1003998, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35671327
18.
Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial.
Lancet
; 397(10290): 2182-2193, 2021 06 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33991479
19.
Transdermal oestradiol for androgen suppression in prostate cancer: long-term cardiovascular outcomes from the randomised Prostate Adenocarcinoma Transcutaneous Hormone (PATCH) trial programme.
Lancet
; 397(10274): 581-591, 2021 02 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-33581820
20.
Experiences of running a stratified medicine adaptive platform trial: Challenges and lessons learned from 10 years of the FOCUS4 trial in metastatic colorectal cancer.
Clin Trials
; 19(2): 146-157, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35083924